SCHEMBL26415690

SCHEMBL26415690

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4oc5cc(-c6ccc7cc(N(c8ccccc8)c8ccccc8)ccc7c6)ccc5c4c3)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.35
ALDH1A1 P00352 4/20 0.35
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
HSD17B10 Q99714 2/20 0.35
CYP1A2 P05177 2/20 0.35
TP53 P04637 1/20 0.35
MMP12 P39900 2/20 0.34
HCRTR1 O43613 1/20 0.34
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CG P48736 1/20 0.32
GAA P10253 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25978938 0.95 ALDH1A1 (0.36) PGRALDH1A1PLA2G2APLA2G4AMEN1
SCHEMBL25975863 0.95 ALDH1A1 (0.36) PGRALDH1A1PLA2G2APLA2G4AMEN1
SCHEMBL25979225 0.94 ALDH1A1 (0.35) PGRALDH1A1PLA2G2APLA2G4AMEN1
SCHEMBL25978941 0.94 ALDH1A1 (0.36) PGRALDH1A1PLA2G2APLA2G4AMEN1
SCHEMBL25979000 0.94 ALDH1A1 (0.36) PGRALDH1A1PLA2G2APLA2G4AMEN1
SCHEMBL25975865 0.93 CYP1A2 (0.37) PGRALDH1A1PLA2G2APLA2G4AMEN1
SCHEMBL26779181 0.93 CYP1A2 (0.39) PGRALDH1A1MEN1KMT2AKDM4E
SCHEMBL25978662 0.93 ALDH1A1 (0.37) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL24574978 0.93 PLA2G2A (0.38) PGRALDH1A1PLA2G2APLA2G4AMEN1
SCHEMBL26416734 0.93 PLA2G2A (0.38) PGRALDH1A1PLA2G2APLA2G4AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 PGR 1532/4885ALDH1A1 27/4885PLA2G2A 4034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.